Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,417,218
-
Total 13F shares
-
8,192,663
-
Share change
-
+587,694
-
Total reported value
-
$97,509,520
-
Put/Call ratio
-
12%
-
Price per share
-
$11.89
-
Number of holders
-
101
-
Value change
-
+$5,576,522
-
Number of buys
-
52
-
Number of sells
-
41
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q1 2025
As of 31 Mar 2025,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,192,663 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock, Inc., BROWN ADVISORY INC, ESSEX INVESTMENT MANAGEMENT CO LLC, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, and Cahill Wealth Management, LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.